Biotechnology Headlines from PR Newswire

< Go Back

Surefire Medical's Groundbreaking COSY Clinical Trial Results Presented at ECIO: Is Coiling Prior to Radioembolization Still Necessary in Minimally Invasive Treatment of Liver Cancer?
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results
Luminex Corporation Announces Norovirus as a Launch Menu Assay for its New Sample-to-Answer System, ARIES™
Amgen's First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion
RXi Pharmaceuticals Enters into Financing Facility with Lincoln Park Capital
Southern Research Institute Develops Novel Screening Capability For Discovery Of Therapeutics To Address Highly Pathogenic Agents
Organogenesis to Present New Apligraf® and Dermagraft® Data at the Symposium on Advanced Wound Care and Wound Healing Society Annual Meeting
Octapharma Funds Observational Treatment Registry Study to Examine the Long Term Effects of Donor Specific Antibodies on Renal Transplant Recipients
Jonathan Hodgson Joins Putnam Associates as Principal
The Global Biosimilars Pipeline Has Expanded by Over 40 Percent in the Last 12 Months
Avalanche Biotechnologies Secures $55 Million in Oversubscribed Series B Financing
Boston Scientific Begins Clinical Trial of ACUITY™ X4 LV Pacing Leads and RELIANCE™ 4-FRONT ICD Leads
Z Trim Expands Distribution Network
Bioject Inc. Adds To Its Global Distribution Network
Guardant Health Announces $30 Million Series B Financing Led By Khosla Ventures
NeuroPhage Discovers GAIM-changing Molecules to Combat Alzheimer's Disease and Other Neurodegenerative Disorders
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C
MiMedx Files Lawsuit Against Liventa, Medline, And Musculoskeletal Transplant Foundation
Union MedTech and Rex Bionics to Exhibit at Master Investor 2014 Conference
AMRI to Announce First Quarter Results
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Presented in Two Sessions at the 2014 American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium & Congress
WuXi PharmaTech Schedules First-Quarter 2014 Earnings Release
Ambit Biosciences to Announce First Quarter 2014 Financial Results
United Therapeutics Corporation To Announce First Quarter 2014 Financial Results Before Market Open On Tuesday, April 29, 2014
BioLife Solutions to Launch biologistex(SM) Service at 20th ISCT Annual Meeting; Precision Thermal Shippers with Embedded Payload Temperature Monitoring and GPS Location Tracking
Fluke Biomedical launches portable, specialized infusion device analyzer Spanish Spanish Portuguese
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014
PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
For Treatment of Ulcerative Colitis (UC), Great Opportunity Exists for Vedolizumab in the U.S. and EU5 Market, Owing to its Novel Mechanism of Action and Promising Efficacy English
New Data From Upsher-Smith's Epilepsy Portfolio To Be Highlighted At The 66th Annual Meeting Of The American Academy Of Neurology English
Veterinary Diagnostics Market worth $4,200 Million by 2018
CASIS Payloads Berthed With the International Space Station Through SpaceX Dragon Capsule
Skip Mendelson joins fast-growing Summit Pharmacy as new VP, sales
Impax Board of Directors Appoints G. Frederick Wilkinson President and CEO
Medtech College Honors Medical Lab Technicians as "Detectives of Disease and Healthcare Symptoms"
Bio-Techne To Host Conference Call On April 28, 2014 To Announce Third Quarter Financial Results
MiMedx Sponsors Scott Rigsby, Double-Amputee
Oxygen Biotherapeutics, Inc. Analyst Report: Positive FDA Catalyst Has Emerging Biopharmaceutical Player Back In the Clinical Trial Business
Can-Fite Initiates the Development of an A3AR Biomarker Test Kit to Predict Patients' Response to Company's Drugs
Spherix Retains Leading Intellectual Property Law Firm to Monetize Patent Portfolio Acquired from Rockstar
Genoa Pharmaceuticals and McMaster University demonstrate inhaled pharmacokinetics enables improved pirfenidone activity with significant promise to enhance IPF treatment safety and tolerability
Medical Affairs Consortium Research Identifies Winning Strategies for Successful Thought Leader Management
LabStyle Innovations Provides Recap of Investor Update Call
Ken Keller Named President, US Commercial, Daiichi Sankyo, Inc.
Cepheid Reports 2014 First Quarter Results
Amgen Announces Webcast of 2014 First Quarter Financial Results
Lumiphore advances its site-directed radiopharmaceutical development program with the receipt of an NSF SBIR Phase II Grant
Adam Scavone Co-Founder of the New York Cannabis Alliance Featured On The Alan Berman Show POT-CAST Brought To You By Verde Media Group Inc.
XBiotech Announces Phase I/II Study Results in Lancet Oncology

< Prev Next >
PR Newswire - United Business Media